Photo by nci from unsplash
e20589Background: Epidermal growth factor receptor (EGFR)tyrosine kinase inhibitors (TKIs) are recommended for patients (pts) with EGFR mutation (EGFRm) positive non-small cell lung cancer (NSCLC).... Click to show full abstract
e20589Background: Epidermal growth factor receptor (EGFR)tyrosine kinase inhibitors (TKIs) are recommended for patients (pts) with EGFR mutation (EGFRm) positive non-small cell lung cancer (NSCLC)....
Keywords:
real world;
outcomes patients;
world outcomes;
understanding real;
patients nsclc;
nsclc progress
Journal Title: Journal of Clinical Oncology
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of Clinical Oncology
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!